IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 33.0837

Change

-0.40 (-1.20)%

Market Cap

N/A

Volume

2.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.39 (-1.81%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.25 (-0.42%)

USD 36.32B
DFAC Dimensional U.S. Core Equity 2..

-0.20 (-0.57%)

USD 31.71B
DTB DTE Energy Company 2020 Series

-0.44 (-2.05%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

-0.01 (-0.02%)

USD 26.27B
SGOV iShares® 0-3 Month Treasury B..

+0.02 (+0.02%)

USD 26.21B
GBTC Grayscale Bitcoin Trust (BTC)

-0.71 (-1.30%)

USD 14.91B
AVUV Avantis® U.S. Small Cap Value..

-1.98 (-2.02%)

USD 14.04B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 13.33B
DFUV Dimensional US Marketwide Valu..

-0.46 (-1.08%)

USD 11.48B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.87% 55% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.87% 56% F 61% D-
Trailing 12 Months  
Capital Gain 31.61% 74% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.61% 75% C 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.45% 75% C 56% F
Dividend Return 5.78% 72% C 49% F
Total Return 0.33% 19% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 7.96% 60% D- 84% B
Risk Adjusted Return 72.64% 82% B 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.